Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001687888-19-000002
Filing Date
2019-02-11
Accepted
2019-02-11 13:38:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 CBIO_13G_A_20190211.htm SC 13G/A 42384
  Complete submission text file 0001687888-19-000002.txt   43916
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 19584288
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734
Business Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734 5127614500
JFL Capital Management, LLC (Filed by) CIK: 0001687888 (see all company filings)

EIN.: 472302073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A